Gene	Mutation	ProtMut	MutReads	WTReads	VAF	Info
ASXL1	chr20:32436210-32436210_Sub:C>G	S1166R	20	18	0.526	Neutral
CBL	chr11:119274894-119274894_Ins:T	L272fs*3	12	128	0.086	Sequencing_artefact
CEBPA	chr19:33301826-33301826_Ins:GCGGGT	P195-P196_Ins:AG	3	9	0.250	Neutral
CEBPA	chr19:33301888-33301888_Sub:G>C	A176G	11	7	0.611	Neutral
CSF3R	chr1:36467309-36467311_Del:CTG	R653-K654_Del:NR	28	421	0.062	Neutral
DNMT3A	chr2:25248124-25248124_Ins:G	T257fs*6	3	4	0.429	Sequencing_artefact
FLT3	chr13:28014452-28015701_ITD	A952-M953_Ins:ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA	11	74	0.129	Oncogenic
FLT3	chr13:28050157-28050157_Sub:G>A	T227M	31	33	0.484	Neutral
GNAS	chr20:58898985-58898985_Ins:GCA	G728-E729_Ins:S	49	348	0.123	Neutral
JAK2	chr9:5069060-5069060_Ins:A	N457fs*1	7	76	0.084	Sequencing_artefact
KIT	chr4:54699764-54699764_Ins:CAG	Q251-T252_Ins:Q	22	215	0.093	Neutral
KIT	chr4:54729485-54731329_Del:GCA	D715_Del:S	48	123	0.281	Neutral
KMT2A	chr11:118471919-118471919_Ins:A	I256fs*1	3	53	0.054	Sequencing_artefact
KMT2A	chr11:118472296-118472296_Ins:A	A383fs*5	3	60	0.048	Sequencing_artefact
KMT2A	chr11:118473941-118473941_Ins:A	A930fs*10	6	36	0.143	Sequencing_artefact
KMT2A	chr11:118491308-118491316_Del:AGGTACAGA	T1604-D1606_Del:GTE	34	8	0.810	Neutral
NPM1	chr5:171392817-171392817_Ins:A	V156fs*5	84	2726	0.030	Sequencing_artefact
NPM1	chr5:171392914-171392914_Ins:A	V156fs*5	140	2767	0.048	Sequencing_artefact
NRAS	chr1:114716120-114716120_Sub:A>G	V14A	3	82	0.035	Neutral
PHF6	chrX:134393951-134393951_Ins:AGC	A139-D140_Ins:A	12	60	0.167	Neutral
PTPN11	chr12:112446397-112450318_Del:AGA	N47_Del:R	4	78	0.049	Neutral
SETBP1	chr18:44950031-44950031_Sub:G>C	V231L	7	0	1.000	Neutral
SF3B1	chr2:197401451-197401451_Ins:A	F815fs*1	61	410	0.130	Sequencing_artefact
SF3B1	chr2:197416765-197416765_Ins:T	K214fs*20	47	375	0.111	Sequencing_artefact
STAG2	chrX:124025891-124025891_Ins:A	N34fs*10	16	260	0.058	Sequencing_artefact
STAG2	chrX:124030967-124030967_Ins:A	G46fs*40	15	237	0.060	Sequencing_artefact
STAG2	chrX:124037596-124037596_Ins:T	I122fs*6	6	243	0.024	Sequencing_artefact
STAG2	chrX:124090952-124090952_Sub:T>C	L1189P	3	82	0.035	Neutral
TET2	chr4:105275672-105275672_Sub:T>G	L1721W	42	70	0.375	Neutral
TET2	chr4:105276119-105276119_Sub:C>T	S1870L	22	26	0.458	Neutral
TET2	chr4:105276349-105276349_Ins:A	V1949fs*6	9	72	0.111	Sequencing_artefact
TP53	chr17:7676154-7676154_Sub:G>C	P72R	39	53	0.424	Neutral
TP53	chr17:7676563-7676563_Sub:T>C	E11G	2	91	0.022	Neutral
U2AF1	chr21:43095697-43095697_Ins:A	F82fs*1	6	95	0.059	Sequencing_artefact
U2AF1	chr21:43104346-43104346_Sub:G>A	S34F	47	43	0.522	Oncogenic